Literature DB >> 19797262

First trimester interleukin 8 levels are associated with postpartum relapse in multiple sclerosis.

Rinze F Neuteboom1, Evert Verbraak, Jane S A Voerman, Marjan van Meurs, Eric A P Steegers, Christianne J M de Groot, Jon D Laman, Rogier Q Hintzen.   

Abstract

Pregnancy has an ameliorating effect on multiple sclerosis (MS), but directly after delivery the risk of a relapse is increased. The pro-inflammatory chemokine interleukin 8 is associated with disease activity. We aimed to investigate whether pregnancy-induced fluctuations of interleukin 8 correlate with periods of enhanced and diminished disease activity. Thirty-six women with MS were prospectively studied before, during and after pregnancy. Serum levels of interleukin 8 were significantly decreased during the third trimester (p = 0.03). High first trimester serum levels of interleukin 8 were associated with a high risk of postpartum relapse (p = 0.007). These results help us to further understand the altered disease course during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19797262     DOI: 10.1177/1352458509107009

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  9 in total

Review 1.  A comprehensive review on the role of chemokines in the pathogenesis of multiple sclerosis.

Authors:  Soudeh Ghafouri-Fard; Kasra Honarmand; Mohammad Taheri
Journal:  Metab Brain Dis       Date:  2021-01-06       Impact factor: 3.584

Review 2.  Sex-related factors in multiple sclerosis susceptibility and progression.

Authors:  Rhonda R Voskuhl; Stefan M Gold
Journal:  Nat Rev Neurol       Date:  2012-03-27       Impact factor: 42.937

3.  Sex and gender issues in multiple sclerosis.

Authors:  Hanne F Harbo; Ralf Gold; Mar Tintoré
Journal:  Ther Adv Neurol Disord       Date:  2013-07       Impact factor: 6.570

Review 4.  Inflammatory Bowel Disease and Reproductive Health: From Fertility to Pregnancy-A Narrative Review.

Authors:  Camilla Ronchetti; Federico Cirillo; Noemi Di Segni; Martina Cristodoro; Andrea Busnelli; Paolo Emanuele Levi-Setti
Journal:  Nutrients       Date:  2022-04-12       Impact factor: 6.706

Review 5.  Pregnancy and multiple sclerosis: from molecular mechanisms to clinical application.

Authors:  Stefan M Gold; Rhonda R Voskuhl
Journal:  Semin Immunopathol       Date:  2016-08-08       Impact factor: 9.623

6.  Cerebrospinal fluid inflammatory markers in patients with multiple sclerosis: a pilot study.

Authors:  Z Matejčíková; J Mareš; H Přikrylová Vranová; J Klosová; V Sládková; J Doláková; J Zapletalová; P Kaňovský
Journal:  J Neural Transm (Vienna)       Date:  2014-06-04       Impact factor: 3.575

7.  Pregnancy in multiple sclerosis: clinical and self-report scales.

Authors:  R F Neuteboom; A C J W Janssens; T A M Siepman; I A Hoppenbrouwers; I A Ketelslegers; N Jafari; E A P Steegers; C J M de Groot; R Q Hintzen
Journal:  J Neurol       Date:  2011-08-03       Impact factor: 4.849

Review 8.  Modulatory Effects of Pregnancy on Inflammatory Bowel Disease.

Authors:  Janine van der Giessen; Vivian W Huang; C Janneke van der Woude; Gwenny M Fuhler
Journal:  Clin Transl Gastroenterol       Date:  2019-03       Impact factor: 4.488

9.  Modulation of cytokine patterns and microbiome during pregnancy in IBD.

Authors:  Janine van der Giessen; Dana Binyamin; Omry Koren; Gwenny Manel Fuhler; Anna Belogolovski; Sigal Frishman; Kinneret Tenenbaum-Gavish; Eran Hadar; Yoram Louzoun; Maikel Petrus Peppelenbosch; Christien Janneke van der Woude
Journal:  Gut       Date:  2019-06-05       Impact factor: 23.059

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.